GoPubMed Proteins lists recent and important papers and reviews for
proteins. Page last changed on 14 Mar 2013.
Cytohesin 1 interacting protein
Cytip, PSCDBP
Sponsored links
Papers on
Cytip
Cytip regulates dendritic-cell function in contact hypersensitivity.
New
Innsbruck, Austria. In Eur J Immunol, Mar 2012
Cytohesin-interacting protein (Cytip) is induced during dendritic cell (DC) maturation and in T cells upon activation.
Role of Cybr, a cytohesin binder and regulator, in CD4(+) T-cell function and host immunity.
GeneRIF
Taipei, Taiwan. In Mol Immunol, 2009
Cybr represses the expression of T-bet and IFN-gamma via an inhibition of p38 in T-cells and consequently reduces host resistance to bacterial infection in mice.
Upregulation of PSCDBP, TLR2, TWIST1, FLJ35382, EDNRB, and RGS12 gene expression in human myometrium at labor.
Galway, Ireland. In Reprod Sci, 2008
Of these, PSCDBP, TLR2, TWIST1 , FLJ35382, andRGS12 have not been previously characterized or identified in human myometrium.
Cybr, CYTIP or CASP: an attempt to pinpoint a molecule's functions and names.
Review
Innsbruck, Austria. In Immunobiology, 2007
The molecule was termed Cybr, CYTIP or CASP for its functions and PSCDBP for its binding properties.
Cytohesin binder and regulator (cybr) is not essential for T- and dendritic-cell activation and differentiation.
GeneRIF
Bethesda, United States. In Mol Cell Biol, 2006
These data suggest that Cybr is not absolutely required for hematopoietic cell development or function, but stem cells lacking Cybr are at a developmental disadvantage compared to wild-type cells.
Cytohesin binder and regulator augments T cell receptor-induced nuclear factor of activated T Cells.AP-1 activation through regulation of the JNK pathway.
Belfast, United Kingdom. In J Biol Chem, 2006
Cytohesin binder and regulator (Cybr; also known as CYTIP, CASP, and PSCDBP) is a cytokine-induced gene preferentially expressed in hematopoietic tissues and in T helper 1 cells.
The scaffold protein Cybr is required for cytokine-modulated trafficking of leukocytes in vivo.
GeneRIF
Frederick, United States. In Mol Cell Biol, 2006
expression in vivo is differentially modulated by type 1 cytokines during lymphocyte maturation
